Aigen Investment Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,419
Closed -$224K 1101
2023
Q2
$224K Buy
+9,419
New +$224K 0.03% 585